Supreme Announces Voting Results for the Annual General Meeting of Shareholders

DECEMBER 16, 2016 TORONTO, ONTARIO — (Marketwired) — 12/16/16 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL)(CSE:SL.CN) announces that at the annual general meeting of its shareholders (the “Meeting“) held in Toronto, Ontario on December 16, 2016, the shareholders approved the election of Mr. Chuck Rifici as a director of the Company. Mr. Rifici joins […]

Supreme Pharmaceuticals Closes $55 Million Offering

DECEMBER 13, 2016 TORONTO, ONTARIO — (Marketwired) — 12/13/16 — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL) is pleased to announce the closing of its $50 million bought deal private placement (the “Brokered Offering“) and concurrent $5 million non-brokered private placement (together with the Brokered Offering, the “Offering“) for aggregate gross proceeds of $55 million. […]

Supreme Pharmaceuticals Announces Additional $5 Million Non-Brokered Private Placement of Convertible Debenture Units

NOVEMBER 17, 2016 TORONTO, ONTARIO –(Marketwired – Nov. 17, 2016 ) – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL)(CSE:SL.CN) is pleased to announce its intention to complete a non-brokered private placement (the “Non-Brokered Offering”) of up to $5 million of convertible debenture units on […]

Supreme Pharmaceuticals Announces $40 Million Bought Deal Private Placement of Convertible Debenture Units

NOVEMBER 14, 2016 Toronto, ON – November 14, 2016 – Supreme Pharmaceuticals Inc. (the “Company”) (CSE: SL) announced today that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $40,000,000 aggregate principal amount of […]

Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal Private Placement Financing to $50 Million

NOVEMBER 15, 2016 Toronto, ON – November 15, 2016 – Supreme Pharmaceuticals Inc. (the “Company”) (CSE: SL) announced today that it has entered into a revised agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) to increase the size of its previously announced bought deal, private placement of convertible debenture […]

Supreme Provides Clarification Regarding Health Canada Website

OCTOBER 27, 2016 TORONTO, ONTARIO — (Marketwired) — 10/27/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(CSE:SL.CN)(OTC PINK:SPRWF) wishes to clarify that, as a result of changes Health Canada made to its website today, Supreme’s operating subsidiary, AMMCan, was mistakenly shown as having been approved for the sale of dried marihuana. Supreme notified IIROC upon […]

Supreme Issues Incentive Stock Options

SEPTEMBER 14, 2016 TORONTO, ONTARIO — (Marketwired) — 09/14/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) has issued 130,000 stock options (each an ” Option “) to a consultant of the Company. Each Option has an exercise price of $0.77 and is exercisable at any time prior to September 14 th , 2021, subject to the terms […]

Supreme Closes Private Placement for Aggregate Proceeds of $14,949,755

AUGUST 30, 2016 TORONTO, ONTARIO — (Marketwired) — 08/30/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the third tranche of its previously announced non-brokered private placement (the “Financing“) for proceeds of $10,610,625 and aggregate proceeds from three tranches of $14,949,755. Pursuant to the Financing, the Company […]

Supreme Closes $4 Million Mortgage

AUGUST 08, 2016 TORONTO, ONTARIO — (Marketwired) — 08/08/16 — Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce that it has closed a $4,000,000 mortgage (the “Mortgage“) with a private lender with respect of its wholly owned subsidiary, 8528934 Canada Ltd. (“7 ACRES“) and the 7 ACRES’ Hybrid Greenhouse in Kincardine, Ontario. The […]

Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34 M and Secures Additional Long-term Supply Agreement

JULY 15, 2016 TORONTO, ONTARIO — (Marketwired) — 07/15/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the second tranche of its previously announced non-brokered private placement (the “Financing“) for proceeds of $723,250 and aggregate proceeds from both tranches of $4,339,130. Upon closing, the company issued 1,808,125 units […]

Supreme Completes First B2B Genetics Sale

JUNE 22, 2016 TORONTO, ONTARIO — (Marketwired) — 06/22/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) via its wholly owned subsidiary is pleased to announce it has completed its first sale of cannabis genetics to another Canadian Licensed Producer (the “LP”). Pursuant to the transaction, Supreme provided the LP with 6 strains for […]

Supreme Closes $3.6 Million Private Placement

JUNE 20, 2016 TORONTO, ONTARIO — (Marketwired) — 06/20/16 — Supreme Pharmaceuticals Inc. (the “Company”) (OTC PINK:SPRWF) (CSE:SL) is pleased to announce that it has closed the first tranche of a non-brokered private placement (the “Financing“) for gross proceeds of $3,615,880 Upon closing, the Company issued 9,039,700 units (each a “Unit“) at a price of $0.40 […]

Supreme Expands B2B Business Through Genetics Agreement

JUNE 06, 2016 TORONTO, ONTARIO — (Marketwired) — 06/06/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF )via its wholly owned subsidiary has entered into a letter of intent with a Canadian Licensed Producer (a “LP”) with respect to the long-term supply by the Company of multiple premium cannabis cultivars for production by the LP. […]

Supreme Secures Multiple Long-term Supply Agreements

MAY 20, 2016 TORONTO, ONTARIO — (Marketwired) — 05/20/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce that its wholly owned subsidiary AMMCan has entered into Letters of Intent (“LOIs”) with respect to the long-term supply of dried cannabis to five (5) Licensed Producers (as such term is defined in the Marihuana […]

Supreme Strengthens Board of Directors

APRIL 25, 2016 TORONTO, ONTARIO — (Marketwired) — 04/25/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce the strengthening of its Board of Directors, following receipt of the federal license to cultivate marijuana at its 7 acre (342,000 sq. ft.) hybrid greenhouse facility in Kincardine, Ontario. Michael La Brier joins […]

Supreme Establishes Strategic Alliance with Dinafem Seeds

APRIL 05, 2016 TORONTO, ONTARIO — (Marketwired) — 04/05/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL) (OTC PINK:SPRWF) is pleased to announce it has established a strategic alliance (the “Strategic Alliance”) with top international cannabis seed developer Dinafem Seeds (“Dinafem”) based in San Sebastian, Spain. Since 2002, Dinafem has been a global leader in the […]

Supreme Hosts Grand Opening of 7ACRE Hybrid Greenhouse Facility

MARCH 30, 2016 TORONTO, ONTARIO — (Marketwired) — 03/30/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL) (OTC PINK:SPRWF) is pleased to report that yesterday over 100 residents, vendors, media representatives, employees and local dignitaries attended a grand opening event at Supreme’s 7 Acre Hybrid Greenhouse in Kincardine, Ontario. Representatives of all levels of local government were […]

Supreme Closes Warrant Incentive Program

MARCH 18, 2016   TORONTO, ONTARIO — (Marketwired) — 03/18/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF) (CSE:SL) is pleased to announce the closing of the limited time incentive program (the “Incentive Program“), which commenced on February 16th, 2016. Pursuant to the Incentive Program, Supreme received aggregate proceeds of $1,013,654.22 through the issuance […]

Supreme Obtains MMPR License to Cultivate Medical Marijuana

MARCH 11, 2016 TORONTO, ONTARIO — (Marketwired) — 03/11/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its wholly-owned subsidiary, Advanced Medical Marihuana Canada (“AMMCan“) has been granted a license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the “MMPR“). About Supreme Supreme is a Canadian publically traded company […]

Supreme Announces Closing of Warrant Incentive Program

JANUARY 08, 2016 January 8, 2016, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce the closing of the limited time incentive program (the “Incentive Program”), which commenced on December 7, 2015. Pursuant to the Incentive Program, Supreme received aggregate proceeds of $2,107,487.25 through the […]